Boston Scientific Noncontrolling interests in subsidiaries increased by 1.3% to $239.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.6%, from $233.00M to $239.00M.
Fluctuations reflect changes in the profitability of partially owned subsidiaries or changes in ownership percentages.
This represents the portion of equity in a subsidiary that is not attributable to the parent company. It reflects the ow...
Common in mining companies that operate through joint ventures or regional subsidiaries.
other_minority_interest| Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $259.00M | $259.00M | $243.00M | $248.00M | $242.00M | $238.00M | $248.00M | $233.00M | $233.00M | $235.00M | $236.00M | $239.00M |
| QoQ Change | — | — | +0.0% | -6.2% | +2.1% | -2.4% | -1.7% | +4.2% | -6.0% | +0.0% | +0.9% | +0.4% | +1.3% |
| YoY Change | — | — | — | — | — | -6.6% | -8.1% | +2.1% | -6.0% | -3.7% | -1.3% | -4.8% | +2.6% |